Solidified Reverse Micellar Solution- (SRMS-) Based Microparticles for Enhanced Oral Bioavailability and Systemic Antifungal Efficacy of Miconazole Nitrate in Immunocompromised Mice

Table 4

Pharmacokinetic parameters of formulations.

Formulation	(μg/mL)	(hr)	AUC (μg/hr/mL)	AUMC (μg/mL/hr^2)	(hr)	(mL)	Clearance (mL/kg/hr)	MRT (hr)
Batch
Batch
Batch
MN powder

MN: miconazole nitrate; Batch : 5% LM₁, containing 3% MN; Batch : 5% LM₂ containing 3% MN; Batch : 5% LM₃ containing 3% MN (values presented as the , ).